Understanding Ectopic Aldosterone-Producing Tumors
At a Glance
An ectopic aldosterone-producing tumor is rare adrenal-like tissue outside the adrenal glands that makes excess aldosterone. Diagnosis combines biochemical testing with imaging or specialized venous sampling, and pathology can confirm the source after removal.
When you are told you have an ectopic aldosterone-producing tumor (EAPT), you are dealing with a medical rarity that sits at the intersection of two complex fields: endocrinology and embryology. To understand this diagnosis, it helps to first look at the “standard” version of the condition and then see how your case has taken a different path.
Because this condition is exceptionally rare, it is important to know what is known and what is uncertain: much of the medical literature on EAPT consists of individual case reports, and many treatment decisions are extrapolated from patients with standard primary aldosteronism caused by adrenal lesions.
The Basics: What is Primary Aldosteronism?
Normally, your adrenal glands (small, triangular organs sitting atop your kidneys) produce a hormone called aldosterone. This hormone acts like a thermostat for your body’s salt and water balance. It tells your kidneys to hold onto sodium and release potassium [1][2].
In primary aldosteronism (PA), this process goes “rogue.” One or both of your adrenal glands begin producing far too much aldosterone, regardless of what your body actually needs. This “renin-independent” overproduction leads to a chain reaction: your body holds onto too much salt and water, which drives up your blood pressure, while your potassium levels often drop too low [3][4]. Most cases of PA are caused by a small growth (an adenoma) in one adrenal gland or by bilateral adrenal hyperplasia (enlargement of both glands). Identifying the subtype drives the choice between surgery and medical treatment.
What Does “Ectopic” Mean?
In medicine, the term ectopic simply means “out of place.” While standard PA originates in the adrenal gland itself, in an ectopic case, the aldosterone-producing tissue is located somewhere else in your body [5][6].
Think of it like a “stray” piece of a factory that was built in the wrong neighborhood. While the tissue looks and acts like an adrenal gland, it is physically located in an unexpected spot, such as:
- The Liver: Adrenal tissue can sometimes be found embedded within the liver [6].
- The Retroperitoneum: This is the space in the back of your abdomen, behind the lining of the abdominal cavity [7].
- The Pancreas or Kidneys: Rare cases have identified these tumors near the tail of the pancreas or the kidneys [7][8].
The “Adrenal-Rest” Tumor
You might hear your doctor use the term adrenal-rest tumor. This refers to a specific quirk of how humans develop before birth. During embryonic development, the tissue that eventually becomes your adrenal glands travels through the abdomen to its final home above the kidneys. Sometimes, tiny “scraps” of this tissue are left behind along the way—these are called adrenal rests [9].
For most people, these rests remain tiny and silent for their entire lives. However, in very rare instances, one of these rests can grow into a functional tumor that starts pumping out aldosterone, just like a standard adrenal tumor would [6].
A Rare Path to Diagnosis
If you feel like it took a long time to get answers, you are not alone. EAPTs are so rare that they are primarily documented in individual case reports rather than large clinical trials [6][7].
The typical localization sequence often follows this pattern:
- Biochemical Confirmation: You are screened for high blood pressure or low potassium using the aldosterone-to-renin ratio (ARR), followed by confirmatory tests [10].
- The Mystery: Blood tests confirm you have primary aldosteronism, but standard imaging (like a CT or MRI) of your adrenal glands might look completely normal [11].
- Advanced Evaluation: Doctors must then search for the “hidden” source. This often involves Adrenal Venous Sampling (AVS)—a procedure where a specialist takes blood samples from the veins draining the adrenals to determine if one side is the primary source. If standard AVS is inconclusive, highly specialized selective or segmental venous sampling might be needed to investigate an extra-adrenal lesion [12][13].
How the Tumor Works
Even though the tumor is in the “wrong” place, it often uses the same biological mechanisms as a standard adrenal tumor. Researchers have found that these tumors often have mutations in specific “ion channels”—essentially the gates that control the electrical charge of a cell [3][14]. When these gates get stuck open, it causes a surge of calcium into the cell, which triggers the production of CYP11B2 (aldosterone synthase), the enzyme responsible for making aldosterone [15][16].
Confirming an EAPT usually requires a combination of three things:
- Biochemical Proof: Blood tests showing high aldosterone and low renin [17].
- Localization: Imaging or AVS showing that the hormone is coming from the ectopic site [6].
- Pathology: After the tumor is removed, specialists use a stain for SF1 (a marker that supports the tissue is adrenal in origin) and CYP11B2 to confirm it was the source of the hormone [9][18].
While the journey to finding an EAPT is often long and complex, identifying the source is the critical step toward targeted treatment and bringing your hormone levels back into balance.
Common questions in this guide
What is an ectopic aldosterone-producing tumor?
Why might a CT or MRI scan of the adrenal glands look normal?
How is an ectopic aldosterone-producing tumor diagnosed?
What is adrenal venous sampling used for in this condition?
What do CYP11B2 and SF1 mean on the pathology report?
How is an ectopic aldosterone-producing tumor treated?
Get notified when new evidence is published on Ectopic aldosterone-producing tumor.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (18)
- 1
Approaches to Gene Mutation Analysis Using Formalin-Fixed Paraffin-Embedded Adrenal Tumor Tissue From Patients With Primary Aldosteronism.
Nanba K, Rainey WE, Udager AM
Frontiers in endocrinology 2021; (12()):683588 doi:10.3389/fendo.2021.683588.
PMID: 34267727 - 2
Role of ACTH and Other Hormones in the Regulation of Aldosterone Production in Primary Aldosteronism.
El Ghorayeb N, Bourdeau I, Lacroix A
Frontiers in endocrinology 2016; (7()):72 doi:10.3389/fendo.2016.00072.
PMID: 27445975 - 3
Pathogenesis and treatment of primary aldosteronism.
Zennaro MC, Boulkroun S, Fernandes-Rosa FL
Nature reviews. Endocrinology 2020; (16(10)):578-589 doi:10.1038/s41574-020-0382-4.
PMID: 32724183 - 4
Genetic causes of primary aldosteronism.
Seidel E, Schewe J, Scholl UI
Experimental & molecular medicine 2019; (51(11)):1-12 doi:10.1038/s12276-019-0337-9.
PMID: 31695023 - 5
Progress on Genetic Basis of Primary Aldosteronism.
Karwacka I, Obołończyk Ł, Kaniuka-Jakubowska S, et al.
Biomedicines 2021; (9(11)) doi:10.3390/biomedicines9111708.
PMID: 34829937 - 6
A case of Williams syndrome with suspected coexisting ectopic aldosterone-producing tumor in the liver.
Baba S, Miyoshi A, Obara S, et al.
Endocrinology, diabetes & metabolism case reports 2020; (2020()).
PMID: 33434178 - 7
Ectopic Adrenocortical Adenoma Causing Malignant Hypertension and Hypokalemia.
Hu X, Arthur Vithran DT, Yang Z, Li H
The American journal of case reports 2025; (26()):e948022 doi:10.12659/AJCR.948022.
PMID: 40702712 - 8
Incidental Detection of Renal Cell Carcinoma on 18 F-NOTA-Pentixather PET/CT in a Patient With Aldosterone-producing Adenoma.
Feng L, Wang H, Zhang W
Clinical nuclear medicine 2025; (50(11)):1097-1098 doi:10.1097/RLU.0000000000005945.
PMID: 40357579 - 9
Overview of the 2022 WHO Classification of Adrenal Cortical Tumors.
Mete O, Erickson LA, Juhlin CC, et al.
Endocrine pathology 2022; (33(1)):155-196 doi:10.1007/s12022-022-09710-8.
PMID: 35288842 - 10
Evaluation and Management of Primary Aldosteronism.
Parisien-La Salle S, Vaidya A
Endocrinology and metabolism clinics of North America 2026; (55(2)):271-284 doi:10.1016/j.ecl.2025.12.002.
PMID: 42067270 - 11
What We Know about and What Is New in Primary Aldosteronism.
Ekman N, Grossman AB, Dworakowska D
International journal of molecular sciences 2024; (25(2)) doi:10.3390/ijms25020900.
PMID: 38255973 - 12
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
Funder JW, Carey RM, Mantero F, et al.
The Journal of clinical endocrinology and metabolism 2016; (101(5)):1889-916 doi:10.1210/jc.2015-4061.
PMID: 26934393 - 13
Subtyping of Primary Aldosteronism in Partial Adrenal Vein Sampling: The Relative Aldosterone Secretion Index.
Rossi FB, Seccia TM, Rossitto G, Rossi GP
Hypertension (Dallas, Tex. : 1979) 2026; (83(7)):e26988 doi:10.1161/HYPERTENSIONAHA.126.26988.
PMID: 42089127 - 14
Somatic Mutations in MCOLN3 in Aldosterone-Producing Adenomas cause Primary Aldosteronism.
van Rooyen D, Bandulik S, Coon G, et al.
bioRxiv : the preprint server for biology 2024; doi:10.1101/2024.10.20.619295.
PMID: 39484451 - 15
Somatic Mutations in MCOLN3 Are Associated With Aldosterone-Producing Adenomas.
van Rooyen D, Bandulik S, Coon GA, et al.
Hypertension (Dallas, Tex. : 1979) 2025; (82(10)):1778-1788 doi:10.1161/HYPERTENSIONAHA.125.24909.
PMID: 40772318 - 16
Somatic SLC30A1 mutations altering zinc transporter ZnT1 cause aldosterone-producing adenomas and primary aldosteronism.
Rege J, Bandulik S, Nanba K, et al.
Nature genetics 2023; (55(10)):1623-1631 doi:10.1038/s41588-023-01498-5.
PMID: 37709865 - 17
Impact of the 2025 Endocrine Society clinical practice guideline on the diagnosis and management of primary aldosteronism for the clinical laboratory.
Sawyer NK, Glendenning P, Schlaich MP, et al.
Pathology 2026; (58(5)):501-506 doi:10.1016/j.pathol.2026.04.003.
PMID: 42362393 - 18
H-score of 11β-hydroxylase and aldosterone synthase in the histopathological diagnosis of adrenocortical tumors.
Yang Y, Xiao M, Song Y, et al.
Endocrine 2019; (65(3)):683-691 doi:10.1007/s12020-019-02022-8.
PMID: 31332713
This page is for informational purposes only and does not constitute medical advice. Your endocrinologist and surgical team should interpret your hormone tests, imaging, and pathology and guide your care.